Table 1 Distribution of malignant and benign lesions according to clinical factors; patient characteristics and sonographic parameters.
Malignant (N = 37) | Benign (N = 25) | Total (N = 62) | p-value* | |
|---|---|---|---|---|
Age, n (%) | ||||
< 50 years | 13(35.14) | 17(68.00) | 30(48.39) | 0.011c |
≥ 50 years | 24(64.86) | 8(32.00) | 32(51.61) | |
BMI, n (%) | ||||
Underweight or normal | 20(54.05) | 10(40.00) | 30(48.39) | 0.277c |
Overweight or obese | 17(45.95) | 15(60.00) | 32(51.61) | |
Bra cup size, n (%) | ||||
A | 18(48.65) | 12(48.00) | 30(48.39) | 0.960c |
B–E | 19(51.35) | 13(52.00) | 32(51.61) | |
Menstrual state, n (%) | ||||
Pre | 13(35.14) | 19(76.00) | 32(51.61) | 0.002c |
Peri or Post | 24(64.86) | 6(24.00) | 30(48.39) | |
Breast parenchyma pattern, n (%) | ||||
A | 0(0.00) | 0(0.00) | 0(0.00) | 0.003f. |
B | 5(13.51) | 2(10.53) | 7(12.50) | |
C | 31(83.78) | 10(52.63) | 41(73.21) | |
D | 1(2.70) | 7(36.84) | 8(14.29) | |
Missing | 0 | 6 | 6 | |
Tumor size, n (%) | ||||
≤ 2 cm | 18(48.65) | 19(76.00) | 37(59.68) | 0.031c |
> 2 cm | 19(51.35) | 6(24.00) | 25(40.32) | |
Distance from skin, n (%) | ||||
≤ 6 mm | 24(64.86) | 11(44.00) | 35(56.45) | 0.104c |
> 6 mm | 13(35.14) | 14(56.00) | 27(43.55) | |
Breast thickness, n (%) | ||||
≤ 2 cm | 20(54.05) | 16(64.00) | 36(58.06) | 0.436c |
> 2 cm | 17(45.95) | 9(36.00) | 26(41.94) | |
Distance from the nipple, n (%) | ||||
≤ 3 cm | 14(37.84) | 16(64.00) | 30(48.39) | 0.043c |
> 3 cm | 23(62.16) | 9(36.00) | 32(51.61) | |
Vascularity, n (%) | ||||
Present | 16(50.00) | 2(9.09) | 18(33.33) | 0.002c |
Absent | 16(50.00) | 20(90.91) | 36(66.67) | |
Missing | 5 | 3 | 8 | |
BI-RADS category, n (%) | ||||
3 | 0(0.00) | 8(32.00) | 8(12.90) | < 0.001f. |
4A | 15(40.54) | 17(68.00) | 32(51.61) | |
4B | 5(13.51) | 0(0.00) | 5(8.06) | |
4C | 7(18.92) | 0(0.00) | 7(11.29) | |
5 | 10(27.03) | 0(0.00) | 10(16.13) | |
Tumor pathology, n (%) | ||||
Malignant | 37(100.00) | 0(0.00) | 37(59.68) | |
DCIS | 3(8.11) | 0(0.00) | 3(4.84) | |
IDC | 19(51.35) | 0(0.00) | 19(30.65) | |
ILC or other malignant | 15(40.54) | 0(0.00) | 15(24.19) | |
Benign | 0(0.00) | 25(100.00) | 25(40.32) | |
